Form 8-K - Current report:
SEC Accession No. 0000939767-25-000074
Filing Date
2025-05-13
Accepted
2025-05-13 16:10:01
Documents
16
Period of Report
2025-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K exel-20250513.htm   iXBRL 8-K 27091
2 EX-99.1 exel20250331exhibit991.htm EX-99.1 118825
6 exel-20250513_g1.jpg GRAPHIC 55431
7 imagea.jpg GRAPHIC 6251
  Complete submission text file 0000939767-25-000074.txt   430058

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exel-20250513.xsd EX-101.SCH 1798
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exel-20250513_lab.xml EX-101.LAB 21885
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exel-20250513_pre.xml EX-101.PRE 12522
19 EXTRACTED XBRL INSTANCE DOCUMENT exel-20250513_htm.xml XML 2806
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Filer) CIK: 0000939767 (see all company filings)

EIN.: 043257395 | State of Incorp.: DE | Fiscal Year End: 0102
Type: 8-K | Act: 34 | File No.: 000-30235 | Film No.: 25940147
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)